Ten largest shareholders as of July 31, 2023
| Name | Series A shares | Series B shares | Share capital % | Voting rights % |
|---|---|---|---|---|
| ANNWALL & ROTHSCHILD INVESTMENT AB | 453 283 | 721 351 | 8.72 | 29.93 |
| SIX SIS AG, W8IMY | 0 | 1 456 078 | 10.81 | 8.30 |
| FJÄRDE AP-FONDEN | 0 | 1 344 000 | 9.98 | 7.66 |
| NORTHERN TRUST COMPANY | 0 | 888 531 | 6.60 | 5.06 |
| AMF AKTIEFOND | 0 | 601 902 | 4.47 | 3.43 |
| TREDJE AP-FONDEN | 0 | 601 894 | 4.47 | 3.43 |
| UNIONEN | 0 | 532 023 | 3.95 | 3.03 |
| SEB AB, LONDON | 0 | 419 515 | 3.11 | 2.39 |
| ÅLANDSBANKEN ABP | 0 | 395 345 | 2.93 | 2.25 |
| DANGOOR, DAVID | 0 | 367 705 | 2.73 | 2.10 |
| Sub-total | 453 283 | 7 328 344 | 57.77 | 67.58 |
| Other shareholders | 0 | 5 689 793 | 42.23 | 32.42 |
| Total | 453 283 | 13 018 137 | 100.00 | 100.00 |
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 453,283 class A shares with 10 votes per share and 13,018,137 class B shares with one vote per share, in total 13,471,420 shares.